NASDAQ:PLSE - Pulse Biosciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$15.89 +0.43 (+2.78 %)
(As of 05/27/2018 04:00 PM ET)
Previous Close$15.89
Today's Range$15.35 - $15.97
52-Week Range$9.81 - $39.50
Volume48,505 shs
Average Volume148,796 shs
Market Capitalization$268.18 million
P/E RatioN/A
Dividend YieldN/A
Beta2.14

About Pulse Biosciences (NASDAQ:PLSE)

Pulse Biosciences logoPulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.

Receive PLSE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PLSE
CUSIPN/A
Phone510-906-4600

Debt

Debt-to-Equity RatioN/A
Current Ratio15.41
Quick Ratio15.41

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$2.43 per share
Price / Book6.54

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-25,560,000.00
Net MarginsN/A
Return on Equity-77.03%
Return on Assets-70.27%

Miscellaneous

Employees33
Outstanding Shares16,880,000

Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences (NASDAQ:PLSE) issued its quarterly earnings data on Tuesday, May, 8th. The company reported ($0.51) earnings per share for the quarter. View Pulse Biosciences' Earnings History.

Who are some of Pulse Biosciences' key competitors?

Who are Pulse Biosciences' key executives?

Pulse Biosciences' management team includes the folowing people:
  • Mr. Darrin R. Uecker, Pres, CEO & Director (Age 52)
  • Mr. Brian B. Dow, Principal Accounting Officer, CFO, Sr. VP of Admin & Fin., Treasurer & Sec. (Age 49)
  • Dr. Richard Nuccitelli Ph.D., Chief Science Officer
  • Dr. Holly Hartman Ph.D., J.D., VP of Bus. Devel. & Corp. Strategy
  • Mr. David Danitz, VP of Engineering

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO.

Has Pulse Biosciences been receiving favorable news coverage?

Media headlines about PLSE stock have been trending somewhat positive this week, according to Accern. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pulse Biosciences earned a news impact score of 0.13 on Accern's scale. They also gave press coverage about the company an impact score of 43.79 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.89%), Northern Trust Corp (0.55%) and Citadel Advisors LLC (0.19%). Company insiders that own Pulse Biosciences stock include Maky Zanganeh, Mitchell E Levinson, Robert J Greenberg, Robert W Duggan and Thierry B Thaure. View Institutional Ownership Trends for Pulse Biosciences.

Which major investors are selling Pulse Biosciences stock?

PLSE stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, BlackRock Inc. and Northern Trust Corp. View Insider Buying and Selling for Pulse Biosciences.

How do I buy shares of Pulse Biosciences?

Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $15.89.

How big of a company is Pulse Biosciences?

Pulse Biosciences has a market capitalization of $268.18 million. Pulse Biosciences employs 33 workers across the globe.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]


MarketBeat Community Rating for Pulse Biosciences (PLSE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  226
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe PLSE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLSE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pulse Biosciences (NASDAQ:PLSE) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/27/2016 forward)

Earnings

Pulse Biosciences (NASDAQ:PLSE) Earnings History and Estimates Chart

Earnings by Quarter for Pulse Biosciences (NASDAQ:PLSE)

Pulse Biosciences (NASDAQ PLSE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018Q1 2018($0.51)ViewN/AView Earnings Details
3/16/2018Q4 2017($0.53)ViewN/AView Earnings Details
11/7/2017Q3 2017($0.52)ViewN/AView Earnings Details
7/27/2017Q2 2017($0.43)ViewN/AView Earnings Details
5/4/2017Q2 2017($0.23)ViewListenView Earnings Details
3/14/2017Q4 2016($0.21)ViewN/AView Earnings Details
11/14/2016Q3 2016($0.21)ViewN/AView Earnings Details
8/10/2016Q2 2016($0.23)ViewN/AView Earnings Details
6/27/2016Q1 2016($0.22)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Pulse Biosciences (NASDAQ:PLSE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Pulse Biosciences (NASDAQ PLSE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 39.30%
Institutional Ownership Percentage: 8.97%
Insider Trading History for Pulse Biosciences (NASDAQ:PLSE)
Insider Trading History for Pulse Biosciences (NASDAQ:PLSE)

Pulse Biosciences (NASDAQ PLSE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2018Robert W DugganDirectorBuy21,353$23.16$494,535.485,862,422View SEC Filing  
12/12/2017Maky ZanganehDirectorBuy4,000$23.07$92,280.00332,500View SEC Filing  
10/19/2017Robert W DugganMajor ShareholderBuy22,901$22.79$521,913.795,820,513View SEC Filing  
9/24/2017Robert W DugganMajor ShareholderBuy2,000,000$15.02$30,040,000.005,797,612View SEC Filing  
9/18/2017Maky ZanganehDirectorBuy29,775$13.36$397,794.00315,725View SEC Filing  
9/18/2017Robert W DugganMajor ShareholderBuy409,918$14.36$5,886,422.483,437,994View SEC Filing  
9/14/2017Mitchell E LevinsonDirectorBuy3,835$12.30$47,170.50View SEC Filing  
8/3/2017Maky ZanganehDirectorBuy28,790$23.96$689,808.40287,225View SEC Filing  
8/3/2017Robert W DugganMajor ShareholderBuy277,450$23.14$6,420,193.003,153,234View SEC Filing  
8/2/2017Maky ZanganehDirectorBuy8,290$25.15$208,493.50287,225View SEC Filing  
5/23/2017Robert W DugganMajor ShareholderBuy83,928$26.86$2,254,306.083,054,244View SEC Filing  
5/22/2017Robert W DugganMajor ShareholderBuy34,728$26.25$911,610.003,054,244View SEC Filing  
5/12/2017Thierry B ThaureDirectorSell10,000$24.40$244,000.0010,000View SEC Filing  
5/11/2017Robert W DugganMajor ShareholderBuy43,389$21.04$912,904.562,984,227View SEC Filing  
5/10/2017Robert J GreenbergDirectorSell25,000$21.12$528,000.0025,000View SEC Filing  
5/8/2017Thierry B ThaureDirectorSell15,000$22.49$337,350.0015,000View SEC Filing  
4/28/2017Robert W DugganMajor ShareholderBuy84,348$23.88$2,014,230.242,958,579View SEC Filing  
4/27/2017Robert W DugganMajor ShareholderBuy35,387$24.79$877,243.732,923,379View SEC Filing  
4/19/2017Robert W DugganMajor ShareholderBuy150,123$23.77$3,568,423.712,601,850View SEC Filing  
4/18/2017Robert W DugganMajor ShareholderBuy61,819$25.49$1,575,766.312,601,850View SEC Filing  
4/17/2017Robert W DugganMajor ShareholderBuy107,300$24.81$2,662,113.002,601,850View SEC Filing  
4/10/2017Robert W. DugganMajor ShareholderBuy191,464$19.75$3,781,414.00View SEC Filing  
3/20/2017Maky ZanganehDirectorBuy18,240$23.34$425,721.60263,935View SEC Filing  
3/18/2017Robert W DugganMajor ShareholderBuy205,127$23.56$4,832,792.122,174,479View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Pulse Biosciences (NASDAQ PLSE) News Headlines

Source:
DateHeadline
Pulse Biosciences (PLSE) Director Buys $494,535.48 in StockPulse Biosciences (PLSE) Director Buys $494,535.48 in Stock
www.americanbankingnews.com - May 15 at 10:12 PM
Pulse Biosciences (PLSE) Lowered to "Sell" at BidaskClubPulse Biosciences (PLSE) Lowered to "Sell" at BidaskClub
www.americanbankingnews.com - May 15 at 12:36 AM
Pulse Biosciences (PLSE) CEO Darrin Uecker on Q1 2018 Results - Earnings Call TranscriptPulse Biosciences' (PLSE) CEO Darrin Uecker on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 9:58 AM
Form S-3 Pulse Biosciences, Inc.Form S-3 Pulse Biosciences, Inc.
www.streetinsider.com - May 11 at 10:10 AM
BRIEF-Pulse Biosciences - Files Prospectus Related To Sale Of Up To 2.1 Mln Shares Of Common StockBRIEF-Pulse Biosciences - Files Prospectus Related To Sale Of Up To 2.1 Mln Shares Of Common Stock
www.reuters.com - May 11 at 10:10 AM
Pulse Biosciences (PLSE) Announces Quarterly  Earnings ResultsPulse Biosciences (PLSE) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 10 at 5:11 PM
Pulse Biosciences (PLSE) & Motus GI (MOTS) Critical SurveyPulse Biosciences (PLSE) & Motus GI (MOTS) Critical Survey
www.americanbankingnews.com - May 8 at 3:04 AM
Pulse Biosciences (PLSE) Stock Rating Upgraded by BidaskClubPulse Biosciences (PLSE) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - May 5 at 6:37 AM
Pulse Biosciences to Report First Quarter 2018 Financial Results and Operational HighlightsPulse Biosciences to Report First Quarter 2018 Financial Results and Operational Highlights
finance.yahoo.com - April 30 at 4:32 PM
Pulse Biosciences (PLSE) Rating Lowered to Sell at BidaskClubPulse Biosciences (PLSE) Rating Lowered to Sell at BidaskClub
www.americanbankingnews.com - April 25 at 12:24 AM
Pulse Biosciences: Failed FDA Clearance, New SEC Investigation, And An Uncertain Path ForwardPulse Biosciences: Failed FDA Clearance, New SEC Investigation, And An Uncertain Path Forward
seekingalpha.com - April 24 at 4:47 PM
Pulse Biosciences (PLSE) Upgraded at BidaskClubPulse Biosciences (PLSE) Upgraded at BidaskClub
www.americanbankingnews.com - April 17 at 9:57 AM
Pulse Biosciences, Inc. (PLSE) Announces Results from Its First Study Evaluating Clinical Target at Major Scientific MeetingPulse Biosciences, Inc. (PLSE) Announces Results from Its First Study Evaluating Clinical Target at Major Scientific Meeting
www.streetinsider.com - April 14 at 4:19 PM
US STOCKS ON THE MOVE-JPMorgan, Citigroup, Glaukos, EyeGate Pharma, Michael KorsUS STOCKS ON THE MOVE-JPMorgan, Citigroup, Glaukos, EyeGate Pharma, Michael Kors
www.nasdaq.com - April 13 at 4:35 PM
Why Alaska Air Group, Pulse Biosciences, and BJs Restaurants Jumped TodayWhy Alaska Air Group, Pulse Biosciences, and BJ's Restaurants Jumped Today
www.fool.com - April 13 at 4:35 PM
BRIEF-Pulse Biosciences Announces Positive Results From Its First Study Evaluating A Clinical Target At Major ...BRIEF-Pulse Biosciences Announces Positive Results From Its First Study Evaluating A Clinical Target At Major ...
www.reuters.com - April 13 at 4:35 PM
FDA Nod For Innovus Kit, PLSE Soars On SK Data, Keep An Eye On ARNAFDA Nod For Innovus' Kit, PLSE Soars On SK Data, Keep An Eye On ARNA
www.nasdaq.com - April 13 at 9:42 AM
Pulse Bios NPS technology shows positive effect in eliminating skin growths; shares up 13% premarketPulse Bio's NPS technology shows positive effect in eliminating skin growths; shares up 13% premarket
seekingalpha.com - April 13 at 9:42 AM
Pulse Biosciences Inc. (PLSE) Is Up Sharply On Study ResultsPulse Biosciences Inc. (PLSE) Is Up Sharply On Study Results
www.nasdaq.com - April 13 at 9:42 AM
Pulse Biosciences stock soars to lead premarket gainers after positive study resultsPulse Biosciences stock soars to lead premarket gainers after positive study results
finance.yahoo.com - April 13 at 9:42 AM
BidaskClub Lowers Pulse Biosciences (PLSE) to SellBidaskClub Lowers Pulse Biosciences (PLSE) to Sell
www.americanbankingnews.com - March 30 at 5:40 PM
Pulse Biosciences Grants Equity Incentive Awards to New Employees - Business Wire (press release)Pulse Biosciences Grants Equity Incentive Awards to New Employees - Business Wire (press release)
www.businesswire.com - March 21 at 4:37 PM
Pulse Biosciences Grants Equity Incentive Awards to New EmployeesPulse Biosciences Grants Equity Incentive Awards to New Employees
finance.yahoo.com - March 21 at 4:37 PM
Pulse Biosciences (PLSE) CEO Darrin Uecker on Q4 2017 Results ... - Seeking AlphaPulse Biosciences' (PLSE) CEO Darrin Uecker on Q4 2017 Results ... - Seeking Alpha
seekingalpha.com - March 18 at 5:18 PM
Pulse Biosciences Quarterly Investor Conference CallPulse Biosciences Quarterly Investor Conference Call
finance.yahoo.com - March 16 at 5:32 PM
Is Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Incentives Align With Yours?Is Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Incentives Align With Yours?
finance.yahoo.com - March 16 at 9:38 AM
Pulse Biosciences (PLSE) and Agilent Technologies (A) Financial ContrastPulse Biosciences (PLSE) and Agilent Technologies (A) Financial Contrast
www.americanbankingnews.com - March 8 at 2:07 PM
Pulse Biosciences (PLSE) Scheduled to Post Quarterly Earnings on MondayPulse Biosciences (PLSE) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - March 5 at 2:34 AM
Pulse Biosciences (PLSE) versus Cynosure (CYNO) Head-To-Head SurveyPulse Biosciences (PLSE) versus Cynosure (CYNO) Head-To-Head Survey
www.americanbankingnews.com - February 24 at 9:12 PM
BidaskClub Lowers Pulse Biosciences (PLSE) to Strong SellBidaskClub Lowers Pulse Biosciences (PLSE) to Strong Sell
www.americanbankingnews.com - February 18 at 1:00 PM
Pulse Biosciences (PLSE) Lifted to "Hold" at ValuEnginePulse Biosciences (PLSE) Lifted to "Hold" at ValuEngine
www.americanbankingnews.com - February 4 at 5:35 PM
Financial Comparison: Pulse Biosciences (PLSE) vs. Its CompetitorsFinancial Comparison: Pulse Biosciences (PLSE) vs. Its Competitors
www.americanbankingnews.com - January 31 at 11:16 AM
Critical Contrast: Pulse Biosciences (PLSE) and The CompetitionCritical Contrast: Pulse Biosciences (PLSE) and The Competition
www.americanbankingnews.com - January 31 at 11:16 AM
Pulse Biosciences Inc (PLSE) Sees Significant Decrease in Short InterestPulse Biosciences Inc (PLSE) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - January 30 at 2:44 PM
Comparing Illumina (ILMN) & Pulse Biosciences (PLSE)Comparing Illumina (ILMN) & Pulse Biosciences (PLSE)
www.americanbankingnews.com - January 29 at 5:14 PM
Pulse Biosciences (PLSE) vs. Reshape Lifesciences (RSLS) Head-To-Head ContrastPulse Biosciences (PLSE) vs. Reshape Lifesciences (RSLS) Head-To-Head Contrast
www.americanbankingnews.com - January 28 at 9:26 AM
Head to Head Survey: Pulse Biosciences (PLSE) vs. The CompetitionHead to Head Survey: Pulse Biosciences (PLSE) vs. The Competition
www.americanbankingnews.com - January 27 at 5:20 PM
Head to Head Analysis: Pulse Biosciences (PLSE) & Its RivalsHead to Head Analysis: Pulse Biosciences (PLSE) & Its Rivals
www.americanbankingnews.com - January 23 at 9:28 PM
Reviewing Pulse Biosciences (PLSE) and The CompetitionReviewing Pulse Biosciences (PLSE) and The Competition
www.americanbankingnews.com - January 20 at 7:50 PM
Pulse Biosciences (PLSE) & Its Competitors Head-To-Head ContrastPulse Biosciences (PLSE) & Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - January 17 at 5:15 PM
Pulse Biosciences (PLSE) vs. Its Peers Head-To-Head ComparisonPulse Biosciences (PLSE) vs. Its Peers Head-To-Head Comparison
www.americanbankingnews.com - January 16 at 1:10 PM
Contrasting Pulse Biosciences (PLSE) and Its PeersContrasting Pulse Biosciences (PLSE) and Its Peers
www.americanbankingnews.com - January 14 at 5:34 PM
Critical Comparison: Pulse Biosciences (PLSE) and Its CompetitorsCritical Comparison: Pulse Biosciences (PLSE) and Its Competitors
www.americanbankingnews.com - January 12 at 9:06 AM
Analyzing Pulse Biosciences (PLSE) & Its PeersAnalyzing Pulse Biosciences (PLSE) & Its Peers
www.americanbankingnews.com - January 12 at 8:04 AM
Pulse Biosciences (PLSE) & The Competition Critical AnalysisPulse Biosciences (PLSE) & The Competition Critical Analysis
www.americanbankingnews.com - January 11 at 11:46 AM
Pulse Biosciences (PLSE) and Luna Innovations (LUNA) Critical AnalysisPulse Biosciences (PLSE) and Luna Innovations (LUNA) Critical Analysis
www.americanbankingnews.com - January 10 at 9:46 AM
Head to Head Review: Pulse Biosciences (PLSE) and The CompetitionHead to Head Review: Pulse Biosciences (PLSE) and The Competition
www.americanbankingnews.com - January 9 at 11:04 AM
Pulse Biosciences (PLSE) and Its Peers Head to Head AnalysisPulse Biosciences (PLSE) and Its Peers Head to Head Analysis
www.americanbankingnews.com - January 8 at 3:30 AM
Analyzing Pulse Biosciences (PLSE) & Its CompetitorsAnalyzing Pulse Biosciences (PLSE) & Its Competitors
www.americanbankingnews.com - January 3 at 11:30 PM
Pulse Biosciences (PLSE) Upgraded to Hold at ValuEnginePulse Biosciences (PLSE) Upgraded to Hold at ValuEngine
www.americanbankingnews.com - January 1 at 12:52 PM

SEC Filings

Pulse Biosciences (NASDAQ:PLSE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Pulse Biosciences (NASDAQ:PLSE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Pulse Biosciences (NASDAQ PLSE) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.